Chen et al., PNAS, vol. 94, pp. 1645-1650, Mar. 1997. |
Verma et al., Nature, vol. 389, pp. 239-242, Sep. 18. 1997. |
Orkin et al., "Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy", Dec. 7, 1995. |
Vrati et al., "Sequence of Ovine Adenovirus Homologs for 100K Hexon Assembly, 33K, pVIII, and Fibre Genes: Early Region E3 is Not in the Expected Location", Virology, vol. 209, Jun. 1, 1995, pp. 400-408. |
Vrati et al., "Construction and Transfection of Ovine, adenovirus Genomic Clones to Rescue Modified Viruses", pp. 200-203. |
Vrati et al., "Unique Genome Arrangements of an Ovine Adenovirus: Identification of New Proteins and Proteinase Cleavage Sites", (1996), pp. 86-199. |
Lemarchand et al., "In Vivo Gene Transfer and Expression in Normal Uninjured Blood Vessels using replication-Deficient Recombinant Adenovirus", pp. 1132-1138. |
Boyle David B. et al., "Characterisation of Australian ovine adenovirus isolates", Veterinary Microbiology, vol. 41, No. 3, 1994, pp. 281-291. |
Stevenson, Susan C. et al, "Human Adenovirus Serotypes 3 and 5 Bind to Two Different Cellular Receptors via the Fiber Head Domain", Journal of Virology, May 1995, vol. 69, No. 5, pp. 2850-2857. |
Taneja, Samir S. et al., "In vitro target specific gene therapy for prostate cancer utilizing a prostate specific antigen promoter-driven adenoviral vector", Proceedings of the American Association for Cancer Research, vol. 35, Mar. 1994, pp. 375, abstract #2236. |